Bfl-1-IN-7 (Compound 25) is a selective, covalent, orally active Bfl-1 inhibitor with an IC50 of 0.015 µM. Bfl-1-IN-7 elicits Caspase activation. Bfl-1-IN-7 can be used in cancer research[1].
Molecular Weight:
461.48
Formula:
C24H26F3N3O3
Target:
Bcl-2 Family,Caspase
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
